李兆基超越李嘉誠成福布斯香港首富
福布斯公布2020年香港富豪榜,恆地(00012.HK)創辦人及前主席李兆基以304億美元(約2,360億港元)身家,超越長和系資深顧問李嘉誠成為香港首富。連續多年為香港首富的李嘉誠以294億美元(約2,282億港元)退居排名榜次位,新世界(00017.HK)及周大福(01929.HK)主席鄭家純以207億美元(約1,607億港元)排名第三。
另外,華人置業(00127.HK)大股東劉鑾雄及銀娛(00027.HK)主席呂志和分別以169億美元及154億美元身家排第四及第五,第6至10位依次為李錦記李文達、郭老太鄺肖卿、吳光正、蔡崇信及楊建文和林惠英夫婦。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.